Vitamin D activities for health outcomes

Annals of Laboratory Medicine

Volumn 34, Issue 3, 2014, Pages 181-186

  Morris, Howard A ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

25 hydroxyvitamin D; Bone fractures; Calcium; Dietary; Metabolic bone diseases; Osteomalacia; Osteoporosis; Vitamin D

Indexed keywords

25-HYDROXYVITAMIN D; CALCITRIOL RECEPTOR; CALCIUM; PROTEIN BINDING; VITAMIN D;

ANALOGS AND DERIVATIVES; FRACTURE; GENETICS; HUMAN; METABOLISM; OSTEOPOROSIS; PATHOLOGY;

CALCIUM; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; PROTEIN BINDING; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 84900408373     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2014.34.3.181     Document Type: Review

References (48)

1. National Health and Medical Research Council (NHMRC), NHMRC additional Levels of Evidence and Grades for Recommendations for Developers of guidelines. https://www.nhmrc.gov.au/-files-nhmrc/file/guidelines/developers/ nhmrc-levels-grades-evidence-120423.pdf.
2. Holick MF. McCollum Award Lecture, 1994: vitamin D-new horizons for the 21st century. Am J Clin Nutr 1994;60:619-30.
3. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012;367:40-9.
4. Ringe JD. The effect of vitamin D on falls and fractures. Scand J Clin Lab Invest Suppl 2012;243:73-8.
5. Rush L, McCartney G, Walsh D, Mackay D. Vitamin D and subsequent all-age and premature mortality: a systematic review. BMC Public Health 2013;13:679.
6. Spedding S, Vanlint S, Morris H, Scragg R. Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients 2013;5:5127-39.
7. Morris HA. Vitamin D 2013: Where do the hyperbole end and the facts begin? Nutr Diet 2013;70:5-6.
8. Morris HA and Anderson PH. Autocrine and paracrine actions of vitamin D. Clin Biochem Rev 2010;31:129-38.
9. Ryan JW, Anderson PH, Turner AG, Morris HA. Vitamin D activities and metabolic bone disease. Clin Chim Acta 2013;425:148-52.
10. Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol 2010;121:88-97.
11. Khanal RC and Nemere I. Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr 2007;17:31-47.
12. Anderson PH, Turner AG, Morris HA. Vitamin D actions to regulate calcium and skeletal homeostasis. Clin Biochem 2012;45:880-6.
13. Anderson PH, Atkins GJ, Turner AG, Kogawa M, Findlay DM, Morris HA. Vitamin D metabolism within bone cells: effects on bone structure and strength. Mol Cell Endocrinol 2011;347:42-7.
14. Anderson PH, O'Loughlin PD, May BK, Morris HA. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Bone 2005;36:654-62.
15. Hendrix I, Anderson P, May B, Morris H. Regulation of gene expression by the CYP27B1 promoter-study of a transgenic mouse model. J Steroid Biochem Mol Biol 2004;89-90:139-42.
16. Bikle DD. Vitamin D and skin: Physiology and pathophysiology. Rev Endocr Metab Disord 2012;13:3-19.
17. Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, et al. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone 2007;40:1517-28.
18. Yang D, Atkins GJ, Turner AG, Anderson PH, Morris HA. Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures. J Steroid Biochem Mol Biol 2013;136:166-70.
19. Anderson PH, Sawyer RK, Moore AJ, May BK, O'Loughlin PD, Morris HA. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 2008;23:1789-97.
20. Brozek W, Manhardt T, Kállay E, Peterlik M, Cross HS. Relative expression of vitamin D hydroxylases, CYP27B1 and CYP24A1, and of cyclooxygenase-2 and heterogeneity of human colorectal cancer in relation to age, gender, tumor location, and malignancy: results from factor and cluster analysis. Cancers (Basel) 2012;4:763-76.
21. Krishnan AV, Swami S, Feldman D. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention. J Steroid Biochem Mol Biol 2013;136:289-95.
22. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006;126:789-99.
23. Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, Slater S, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 2008;66(10 S2):S98-S112.
24. Engel KB and Yamamoto KR. The glucocorticoid receptor and the coregulator Brm selectively modulate each other's occupancy and activity in a gene-specific manner. Mol Cell Biol 2011;31:3267-76.
25. Dwivedi PP, Hii CS, Ferrante A, Tan J, Der CJ, Omdahl JL, et al. Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5. J Biol Chem 2002;277:29643-53.
26. Boland RL. VDR activation of intracellular signaling pathways in skeletal muscle. Mol Cell Endocrinol 2011;347:11-6.
27. Nemere I, Farach-Carson MC, Rohe B, Sterling TM, Norman AW, Boyan BD, et al. Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. Proc Natl Acad Sci USA 2004;101:7392-7.
28. Bravo S, Paredes R, Izaurieta P, Lian JB, Stein JL, Stein GS, et al. The classic receptor for 1alpha,25-dihydroxy vitamin D3 is required for non-genomic actions of 1alpha,25-dihydroxy vitamin D3 in osteosarcoma cells. J Cell Biochem 2006;99:995-1000.
29. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 2005;26:898-915.
30. Rawadi G and Roman-Roman S. Wnt signalling pathway: a new target for the treatment of osteoporosis. Expert Opin Ther Targets 2005;9:1063-77.
31. Rosen JF, Fleischman AR, Finberg L, Hamstra A, DeLuca HF. Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr 1979; 94:729-35.
32. Liberman UA, Samuel R, Halabe A, Kauli R, Edelstein S, Weisman Y, et al. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet 1980; 1:504-6.
33. Brooks MH, Bell NH, Love L, Stem PH, Orfei E, Queener SF, et al. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med 1978;298:996-9.
34. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997;94: 9831-5.
35. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histmorphometric and biomechanical analyses. Endocrinology 1999;140:4982-7.
36. Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P, et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest 2012;122:1803-15.
37. Xue Y and Fleet JC. Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology 2009;136: 1317-27.
38. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberhertt M, Gniadecki R, et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 2002;16:1524-37.
39. Cochran M, Coates PT, Morris HA. The effect of calcitriol on fasting urine calcium loss and renal tubular reabsorption of calcium in patients with mild renal failure-actions of a permissive hormone. Clin Nephrol 2005; 64:98-102.
40. Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004;279: 16754-66.
41. Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T, Sekine K, et al. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology 2013;154:1008-20.
42. Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baasten P, et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest 2012;122:1803-15.
43. Gardiner EM, Baldock PA, Thomas GP, Sims NA, Henderson NK, Hollis B, et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J 2000;14:1908-16.
44. Misof BM, Roschger P, Tesch W, Baldock PA, Valenta A, Messmer P, et al. Targeted overexpression of vitamin D receptor in osteoblasts increases calcium concentration without affecting structural properties of bone mineral crystals. Calcif Tissue Int 2003;73:251-7.
45. Anderson PH, Sawyer RK, Moore AJ, May BK, O'Loughlin PD, Morris HA. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 2008;23:1789-97.
46. Lee AM, Sawyer RK, Moore AJ, Morris HA, O'Loughlin PD, Anderson PH. Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume. J Steroid Biochem Mol Biol 2013 Dec 2. pii: S0960-0760(13)00263-X. doi: 10.1016/j.jsbmb.2013.11.009. [Epub ahead of print]
47. St-Arnaud R and Naja RP. Vitamin D metabolism, cartilage and bone fracture repair. Mol Cell Endocrinol 2011;347:48-54.
48. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014;2:76-89.